Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Community-acquired pneumonia

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Shock, severe hypoxaemia, respiratory exhaustion, rapidly progressive infiltrates, altered consciousness, inability to protect the airway or need for ventilatory support requires immediate sepsis/critical-care escalation. Do not wait for a CURB65 total or chest radiograph before stabilising ABCDE and giving timely antibiotics.

Synopsis

Diagnose pneumonia clinically and radiographically where appropriate, use CRB65/CURB65 plus judgement to select care, and give severity-matched antibiotics, oxygen and adjunctive treatment with explicit review points.

  • CAP is an acute lower respiratory infection acquired outside hospital with compatible clinical features and, in hospital, usually new radiographic shadowing not explained by another cause.
  • Assess ABCDE, SpO2, sepsis physiology, ability to take oral medicines, frailty/comorbidity and social support before scoring severity.
  • CRB65 in the community and CURB65 in hospital support risk assessment: Confusion, urea above 7 mmol/L, respiratory rate at least 30/min, low BP, age 65 or over; each scores 1.
  • Scores supplement judgement. Profound hypoxaemia, shock, multilobar disease, immunosuppression or rapid deterioration can indicate high severity despite a low number.
  • Low-severity adult CAP: amoxicillin 500 mg orally three times daily for 5 days; doxycycline 200 mg day 1 then 100 mg daily or clarithromycin 500 mg twice daily are alternatives when appropriate.
  • Moderate severity: amoxicillin 500 mg TDS for 5 days, adding clarithromycin 500 mg BD if atypical pathogens are suspected; doxycycline or clarithromycin alone can be alternatives in penicillin allergy.
  • High severity: co-amoxiclav 500/125 mg orally TDS or 1.2 g IV TDS plus clarithromycin 500 mg BD (oral/IV as appropriate), review route and total duration at 5 days.
  • Use oral antibiotics first if the person can take them and severity does not require IV; review IV therapy by 48 hours and switch promptly when improving.
  • Stop antibiotics after 5 days unless microbiology requires longer or the person is not clinically stable; instability includes fever in the preceding 48 hours or more than one ongoing sign such as tachycardia, tachypnoea or low BP.
  • NICE 2025 recommends considering IV hydrocortisone in high-severity CAP in hospital for 4-7 days or until discharge sooner; monitor hyperglycaemia and secondary infection.
  • Key red flags

    High-severity CAP

    CURB65 3-5 and/or clinical shock, profound hypoxaemia, rapid progression or need for ventilatory/vasopressor support. Seek critical-care input early and treat promptly.

    Parapneumonic effusion/empyema

    Persistent fever, pleuritic pain, dullness or a pleural collection on imaging requires ultrasound and pleural-fluid assessment/drainage pathway; antibiotics alone may fail.

    Alternative diagnosis

    Pulmonary embolism, oedema, malignancy/obstruction, alveolar haemorrhage, organising pneumonia or aspiration can mimic CAP. Reconsider with atypical imaging, haemoptysis, recurrent same-lobe disease or treatment failure.

    Immunocompromised host

    Neutropenia, transplant, advanced HIV or substantial immunosuppression expands pathogen range and invalidates routine uncomplicated CAP assumptions; obtain early infection/respiratory specialist input.

    Investigation priorities

    01
    CRB65/CURB65 plus clinical judgementFirst step

    Estimate mortality risk and guide place/intensity of care.

    Management branches

    First hourAssess severity and treat

    Suspected CAP with systemic illness or hospital presentation.

    1. ABCDE, SpO2, sepsis assessment and CRB65/CURB65; obtain CXR and relevant cultures promptly without delaying antibiotics in unstable disease.
    2. Give oxygen to 94-98%, or 88-92% if hypercapnic risk. Give oral antibiotic first if feasible; use IV when high severity, vomiting, absorption concern or critical illness requires it.
    3. Assess fluids, VTE prophylaxis, analgesia/antipyresis and critical-care need. Use cautious fluid boluses with reassessment in older adults or cardiac/renal disease.
    4. Record antibiotic indication, allergy, route, start time, planned 48-hour IV review and 5-day stop/review date.

    Key medicines

    Amoxicillin500 mg orally three times daily for 5 days; higher doses may be used for severe infection according to BNF/renal function.Check immediate/non-immediate penicillin allergy, renal function and rash/diarrhoea; adjust when required. Does not cover atypical organisms.
    Doxycycline200 mg orally on day 1, then 100 mg once daily on days 2-5.Avoid in pregnancy; take with plenty of water while upright and separate from iron/calcium/antacids. Photosensitivity and oesophagitis can occur.
    Open full textbook →Answer 2 questions
    Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
    Sources

    Sources and review status

    National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

    • NICE NG250: pneumonia diagnosis and managementSeptember 2025 severity, investigation, antibiotic, duration and corticosteroid recommendations.
    • NICE NG250 adult CAP hospital visual summaryHospital antibiotic and adjunctive-treatment pathway.
    • NICE NG250 adult CAP primary-care visual summaryCRB65 and oral antibiotic regimens.
    • BTS emergency oxygen guidelinePneumonia oxygen targets and controlled oxygen in hypercapnic risk.
    • MHRA fluoroquinolone restrictionsCurrent restrictions where alternative antibiotics are appropriate.

    Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

    Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom